Julie S.
About Julie S.
Julie S. serves as the Director of Cell Therapy Process Development at Sana Biotechnology, Inc., where she has worked since 2023. With extensive experience in cell therapy and gene delivery, she has held various significant roles in prominent organizations, including Bristol Myers Squibb and Juno Therapeutics.
Work at Sana Biotechnology
Julie S. serves as the Director of Cell Therapy Process Development at Sana Biotechnology, Inc. since 2023. In this role, she focuses on advancing cell therapy processes, contributing to the company's mission of developing transformative therapies for patients. Her position is based in Seattle, Washington, where she leads initiatives to enhance the efficiency and effectiveness of cell therapy development.
Education and Expertise
Julie S. holds a Doctor of Philosophy in Bioengineering from the University of Washington, where she studied from 2008 to 2013. She also earned a Bachelor of Science in Chemical-Biological Engineering from the Massachusetts Institute of Technology (MIT), with minors in Biomedical Engineering and East Asian Studies. Her academic background underpins her expertise in early-stage process development for autologous and allogeneic cell therapies.
Background
Julie S. has a diverse professional background in the biotechnology sector. She began her career as an Undergraduate Research Assistant at MIT and has held various positions, including roles at Juno Therapeutics, Bristol Myers Squibb, and the University of Toronto. Her experience spans research and development in cell therapy, gene delivery, and process engineering, providing her with a comprehensive understanding of the field.
Achievements
Julie S. has accumulated over eight years of hands-on experience in process development for cell therapies. Her work includes significant contributions to the development of lipid and polymer nanoparticles for non-viral gene delivery. She specializes in transitioning technologies from research to product development, effectively bridging the gap between scientific innovation and practical application in drug development.